Lower limb events in individuals with type 2 diabetes: evidence for an increased risk associated with diuretic use
Autor: | Pierre-Jean Saulnier, Michel Marre, Kamel Mohammedi, Louis Potier, Ronan Roussel, Samy Hadjadj, Stéphanie Ragot, Fabrice Schneider, Odette Matar, Anisoara Bumbu, Gilberto Velho |
---|---|
Přispěvatelé: | Service d'endocrinologie, diabétologie et nutrition [CHU Bichat], Université Paris Diderot - Paris 7 (UPD7)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Sorbonne Paris Cité (USPC), Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Sorbonne Université (SU), CIC - Poitiers, Université de Poitiers-Centre hospitalier universitaire de Poitiers (CHU Poitiers)-Direction Générale de l'Organisation des Soins (DGOS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Poitiers - Faculté de Médecine et de Pharmacie, Université de Poitiers, Centre hospitalier universitaire de Poitiers (CHU Poitiers), Fondation Ophtalmologique Adolphe de Rothschild [Paris], Hôpital Haut-Lévêque [CHU Bordeaux], CHU Bordeaux [Bordeaux], Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Bordeaux (UB), unité de recherche de l'institut du thorax UMR1087 UMR6291 (ITX), Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre hospitalier universitaire de Nantes (CHU Nantes), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris]-Université Paris Diderot - Paris 7 (UPD7), École pratique des hautes études (EPHE)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU) |
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Male
0301 basic medicine medicine.medical_specialty Side effect Endocrinology Diabetes and Metabolism medicine.medical_treatment [SDV]Life Sciences [q-bio] 030209 endocrinology & metabolism Type 2 diabetes Amputation Surgical 03 medical and health sciences 0302 clinical medicine Lower limb revascularisation Internal medicine Internal Medicine medicine Humans Hypoglycemic Agents Prospective Studies Canagliflozin Diuretics Sodium-Glucose Transporter 2 Inhibitors Aged Lower limb amputation business.industry Incidence (epidemiology) Middle Aged medicine.disease 3. Good health 030104 developmental biology Increased risk Diabetes Mellitus Type 2 Lower Extremity Multivariate Analysis Cohort Female Observational study Diuretic business medicine.drug |
Zdroj: | Diabetologia Diabetologia, Springer Verlag, 2019, 62 (6), pp.939-947. ⟨10.1007/s00125-019-4835-z⟩ |
ISSN: | 0012-186X 1432-0428 |
DOI: | 10.1007/s00125-019-4835-z⟩ |
Popis: | International audience; AIMS/HYPOTHESIS : Recently, safety data signalled an increased risk of amputations in people taking canagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor. If this side effect is due to drug-induced hypovolaemia, diuretics should also increase that risk. The aim of this study was to analyse the association between diuretic use and the risk of lower limb events (LLEs) in people with type 2 diabetes.METHODS : SURDIAGENE (SUivi Rénal, DIAbète de type 2 et GENEtique) is a prospective observational cohort that includes people with type 2 diabetes enrolled from 2002 to 2012 and followed-up until onset of LLE, death or 31 December 2015, whichever came first. Primary outcome was the first occurrence of LLE, a composite of lower limb amputation (LLA) and lower limb revascularisation (LLR). The rates of primary outcome were compared between participants taking and not taking diuretics at baseline in a Cox-adjusted model.RESULTS : At baseline, of the 1459 participants included, 670 were taking diuretics. In participants with and without diuretics, the mean ages were 67.1 and 62.9 years and 55.8% and 59.8% were men, respectively. During a median follow-up of 7.1 years, the incidence of LLE was 1.80 per 100 patient-years in diuretic users vs 1.00 in non-users (p |
Databáze: | OpenAIRE |
Externí odkaz: |